Maynard Um
-
-
-
-
-
-
-
Baird on Lineage Cell Therapeutics Inc. (LCTX): 'Incrementally positive following partner's R&D Day'
-
-
-
-
-
-
-
Lineage Cell Therapeutics (LCTX) Tops Q4 EPS by 2c
-
-
-
-
-
-
-
Lineage Cell Therapeutics (LCTX) Misses Q2 EPS by 3c
401,645 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

